Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
National Medical Research Center of Cardiology, Moscow (Russian Federation)
57 More presentations in this session
Mrs A. Boulmpou (Nijmegen, NL)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Session
Congress Presentation
